Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received February 20, 2019
- Revision received March 27, 2019
- Accepted March 27, 2019
- Published online April 5, 2019.
Copyright & Usage
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
Author Information
- RACHEL A. CROSSLEY1,*,
- ALYSSA MATZ2,*,
- TERRY DEW3,
- ASHLEY KALINAUSKAS3,
- NICOLE FAUCETTE1,
- BRAD POFF3,
- LAWRENCE K. SILBART2 and
- MARK A. SUCKOW3,4⇑
- 1Department of Pathobiology and Veterinary Science, College of Agriculture, Health and Natural Resources, University of Connecticut, Storrs, CT, U.S.A.
- 2Department of Molecular and Cell Biology, College of Liberal Arts and Sciences, University of Connecticut, Storrs, CT, U.S.A.
- 3Torigen Pharmaceuticals, Inc., Farmington, CT, U.S.A.
- 4Department of Biomedical Engineering, University of Kentucky, Lexington, KY, U.S.A.
- Correspondence to: Mark A. Suckow, Department of Biomedical Engineering, University of Kentucky, Lexington, 40506 KY, U.S.A. Tel: +1 8592571117, e-mail: msuckow{at}uky.edu
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients
- In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma
- Extracellular matrix scaffold-assisted tumor vaccines induce tumor regression and long-term immune memory
- Use of Conditioned Extracellular Matrix as a Tissue-engineered Tumor Matrisome for Prostate Cancer and Melanoma Immunotherapy